#ophthalmology

@ophthalmology.bsky.social

13 hours ago

Assessment and management of dry eye disease in the UK: standardising reality-based best practice Eye, Published online: 14 March 2026; doi:10.1038/s41433-026-04375-7Assessment and management of dry eye disease in the UK: standardising reality-based best practice

Ophthopedia Update: Assessment and management of dry eye disease in the UK: standardising reality-based best practice: Eye, Published online: 14 March 2026; doi:10.1038/s41433-026-04375-7Assessment and management of dry eye disease in the UK: standardising… #Ophthalmology #Eye #Ophthotwitter

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

13 hours ago

Clinical spectrum of intraocular inflammation following faricimab intravitreal injections: evidence from a large real-life cohort in the United Kingdom Eye, Published online: 14 March 2026; doi:10.1038/s41433-026-04371-xClinical spectrum of intraocular inflammation following faricimab intravitreal injections: evidence from a large real-life cohort in the United Kingdom

Ophthopedia Update: Clinical spectrum of intraocular inflammation following faricimab intravitreal injections: evidence from a large real-life cohort in the United Kingdom: Eye, Published online: 14 March 2026; doi:10.1038/s41433-026-04371-xClinical spectrum of… #Ophthalmology #Eye #Ophthotwitter

0 0 0 0

CU Anschutz Department of Ophthalmology

@cueyecenter.bsky.social

1 day ago

Research featuring Lynn Hassman, MD, PhD in American Academy of Ophthalmology finds weekly adalimumab dosing helped over 50% of patients with noninfectious uveitis achieve treatment success in six months.

Read more: https://bit.ly/4b5KmOs

#Ophthalmology #Uveitis #EyeCare

0 1 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

Week in Review: Reimagining Ophthalmic Education, Personalized Coaching Programs for Improving Glaucoma Medication Adherence A survey of ophthalmologists-in-training finds dissatisfaction with their ophthalmic education, and one aid to glaucoma medication adherence may be an individualized training program.

Ophthopedia Update: Week in Review: Reimagining Ophthalmic Education, Personalized Coaching Programs for Improving Glaucoma Medication Adherence: A survey of ophthalmologists-in-training finds dissatisfaction with their ophthalmic education, and one aid to glaucoma medication… #Ophthalmology #News

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

Bimatoprost implant reduces IOP, improves vision at 12 months Editor’s note: This is a developing news story. Please check back soon for updates. At 12 months in a phase 1/2 trial, the Bimatoprost Drug Pad-IOL System improved IOP, vision and treatment burden in patients with open-angle glaucoma or ocular hypertension with concomitant cataract. According to a press release from SpyGlass Pharma, 104 patients were randomly assigned 2:1:1 to receive 78 µg Bimatoprost Drug Pad-IOL System (BIM-IOL System) (51 patients) with daily administration of artificial tear drops, 39 µg BIM-IOL System (23 patients) with daily administration of artificial tear drops, or

Ophthopedia Update: Bimatoprost implant reduces IOP, improves vision at 12 months: Editor’s note: This is a developing news story. Please check back soon for updates.
At 12 months in a phase 1/2 trial, the Bimatoprost Drug Pad-IOL System improved IOP, vision and… #ophthalmology #eye #eyenews

2 0 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

Delphi Panel Develops Systemic Surveillance Guidelines for Uveal Melanoma A multidisciplinary group created consensus-based guidelines for systemic monitoring in patients with intermediate- or high-risk uveal melanoma, a malignancy with a high rate of metastasis.

Ophthopedia Update: Delphi Panel Develops Systemic Surveillance Guidelines for Uveal Melanoma: A multidisciplinary group created consensus-based guidelines for systemic monitoring in patients with intermediate- or high-risk uveal melanoma, a malignancy with a high rate of… #Ophthalmology #News

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: an updated systematic review and meta-analysis Acute central serous chorioretinopathy (CSC) may resolve spontaneously, but risks progression to chronic disease with visual impairment.We performed a PRISMA-compliant meta-analysis evaluating photodynamic therapy (PDT) and anti-vascular endothelial growth factor (VEGF) agents versus observation in acute CSC (

Ophthopedia Update: Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: an updated systematic review and meta-analysis: Acute central serous chorioretinopathy (CSC) may resolve spontaneously, but risks… #Ophthalmology #Eye #Ophthotwitter

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

BlackDoctor Pro adds cultural fluency for health care providers A new clinical delivery model offers resources to help health care providers, or HCPs, become more culturally competent and improve health outcomes for their Black patients, an expert said. BlackDoctor is a “leading health and wellness destination for Black people” that works to “leverage culture, content and technology to transform people’s lives for the better,” according to its website. But now, it is expanding beyond a consumer health platform to become a dual-platform clinical delivery model, according to a press release. There are some key aspects to the expansion rollout: BlackDoctor

Ophthopedia Update: BlackDoctor Pro adds cultural fluency for health care providers: A new clinical delivery model offers resources to help health care providers, or HCPs, become more culturally competent and improve health outcomes for their Black patients, an expert… #ophthalmology #eye #eyenews

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

VIDEO: Optogenetic therapy represents ‘completely different approach to GA’ In this video from the Macula Society meeting, Theodore Leng, MD, FACS, discusses MCO-010, an optogenetic therapy from Nanoscope Therapeutics under study for advanced retinitis pigmentosa and geographic atrophy. “This program is actually planning to launch a phase 2 trial for GA in 2026,” Leng, professor of ophthalmology and director of clinical and translational research at Byers Eye Institute, Stanford University, said. “I think this represents a completely different approach to GA, shifting from slowing disease progression via the complement inhibition to potentially

Ophthopedia Update: VIDEO: Optogenetic therapy represents ‘completely different approach to GA’: In this video from the Macula Society meeting, Theodore Leng, MD, FACS, discusses MCO-010, an optogenetic therapy from Nanoscope Therapeutics under study for advanced… #ophthalmology #eye #eyenews

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

VIDEO: Early, continuous pegcetacoplan treatment improves GA outcomes In this video from the Macula Society meeting, Theodore Leng, MD, FACS, discusses 5-year data on pegcetacoplan, from Apellis, for geographic atrophy. “This presentation really supported the notion that earlier and continuous treatment yielded better outcomes for preserving retinal tissue and delaying GA progression in the long term,” Leng, professor of ophthalmology and director of clinical and translational research at Byers Eye Institute, Stanford University, said.

Ophthopedia Update: VIDEO: Early, continuous pegcetacoplan treatment improves GA outcomes: In this video from the Macula Society meeting, Theodore Leng, MD, FACS, discusses 5-year data on pegcetacoplan, from Apellis, for geographic atrophy.
“This presentation really… #ophthalmology #eye #eyenews

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

VIDEO: Simultaneous management of GA, neovascular AMD ‘feasible and safe’ In this video from the Macula Society meeting, Theodore Leng, MD, FACS, discusses research on managing coexisting geographic atrophy and neovascular age-related macular degeneration in the same eye. “Historically, we haven’t had much real-world data looking at how dual therapies interact outside of clinical trials,” Leng, professor of ophthalmology and director of clinical and translational research at Byers Eye Institute, Stanford University, said. Leng explained how the treatments work in terms of efficacy and scheduling. “The main takeaway was that we found that managing these two conditions

Ophthopedia Update: VIDEO: Simultaneous management of GA, neovascular AMD ‘feasible and safe’: In this video from the Macula Society meeting, Theodore Leng, MD, FACS, discusses research on managing coexisting geographic atrophy and neovascular age-related macular… #ophthalmology #eye #eyenews

0 0 0 0

Computer America

@computeramerica.bsky.social

1 day ago

Hair Loss Breakthrough: Light Therapy Suppresses Key Markers by 92% Show Notes 13 March 2026 Story 1: 3D Printing Soft Robots - Rotational multi-material printing offers intricate, programmable shapesSource: Harvard School of Engineering Story by Anne J. Manning Link: https://seas.harvard.edu/news/3d-printing-soft-robots See video here: https://www.youtube.com/watch?v=BK9K_mJjlxE Story 2: AI robot vehicles learn to team up and extinguish fires in early trial Source: TechXplore.com Story by Andrew Zinin Link: https://techxplore.com/news/2026-02-ai-robot-vehicles-team-extinguish.html See research paper here: https://www.sciencedirect.com/science/article/pii/S0952197626000618?via%3Dihub Story 3: New Light Therapy Can Suppress a Key Marker of Hair Loss by 92%Source: ScienceAlert.com Story by Carly CassellaLink: https://www.sciencealert.com/new-light-therapy-can-suppress-a-key-marker-of-hair-loss-by-92 Story 4: Mapping Protein Production in Brain Cells Yields New Insights for Brain Disease - UC San Diego and Scripps Research scientists used a novel method to show that some memory neurons produce proteins at higher rates than others. Source: UC San Diego Today Story by Susanne Clara Bard Link: https://today.ucsd.edu/story/mapping-protein-production-in-brain-cells-yields-new-insights-for-brain-disease

📣 New Podcast! "Hair Loss Breakthrough: Light Therapy Suppresses Key Markers by 92%" on @Spreaker #3d #artificial #brain #dermatology #disease #engineering #firefighting #hair #intelligence #loss #mapping #medical #neuroscience #ophthalmology #printing #protein #research #robotics #robots #soft

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

Trends in retinopathy of prematurity (ROP) training and future practice intentions among retina and pediatric ophthalmology fellows To assess the perspectives of pediatric ophthalmology and retina fellows on retinopathy of prematurity (ROP) training in fellowship and future ROP practice intentions.

Ophthopedia Update: Trends in retinopathy of prematurity (ROP) training and future practice intentions among retina and pediatric ophthalmology fellows: To assess the perspectives of pediatric ophthalmology and retina fellows on retinopathy of prematurity (ROP)… #Ophthalmology #Eye #Ophthotwitter

0 0 0 0

Canadian Journal of Ophthalmology

@cjo-jco.bsky.social

1 day ago

An infographic that summarizes the main findings of a study titled "Comparative efficacy of aflibercept, bevacizumab, and ranibizumab on hard exudate resolution in diabetic macular edema" from the February 2026 issue of The Canadian Journal of Ophthalmology.

This month’s visual abstract summarizes a study that compares the efficacy of aflibercept, bevacizumab, and ranibizumab for resolution of diabetic macular edema-associated hard exudates (HEs).

bit.ly/cjo_comparin...

#Ophthalmology #Retina #DiabeticMacularEdema

0 1 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

Early Real-World Anatomic Response and Interval Extension After Switching to Aflibercept 8 mg in Previously Treated Eyes With Neovascular AMD or Pachychoroid-Related Macular Neovascularization Publication date: Available online 9 March 2026 Source: AJO International Author(s): Maria Emfietzoglou, Solomon Frances, Alexander Charonis

ICYMI: Ophthopedia Update: Early Real-World Anatomic Response and Interval Extension After Switching to Aflibercept 8 mg in Previously Treated Eyes With Neovascular AMD or Pachychoroid-Related Macular Neovascularization: Publication date: Available online 9 March… #Ophthalmology #AJOInternational

0 0 0 0

AJO International

@ajoint.bsky.social

1 day ago

👁️ Telemedicine-based glaucoma screening in Latine individuals with limited English proficiency. 
#Ophthalmology #Glaucoma #Telemedicine #HealthEquity

🔗 www.sciencedirect.com/science/arti...

0 1 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

Are amblyopia therapy outcomes related to socioeconomic situation for children in Greater Manchester? Eye, Published online: 13 March 2026; doi:10.1038/s41433-026-04280-zAre amblyopia therapy outcomes related to socioeconomic situation for children in Greater Manchester?

Ophthopedia Update: Are amblyopia therapy outcomes related to socioeconomic situation for children in Greater Manchester?: Eye, Published online: 13 March 2026; doi:10.1038/s41433-026-04280-zAre amblyopia therapy outcomes related to socioeconomic situation for… #Ophthalmology #Eye #Ophthotwitter

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

Management of traumatic corneal wounds that do not seal after primary closure: a systematic review Eye, Published online: 13 March 2026; doi:10.1038/s41433-026-04352-0Management of traumatic corneal wounds that do not seal after primary closure: a systematic review

Ophthopedia Update: Management of traumatic corneal wounds that do not seal after primary closure: a systematic review: Eye, Published online: 13 March 2026; doi:10.1038/s41433-026-04352-0Management of traumatic corneal wounds that do not seal after primary… #Ophthalmology #Eye #Ophthotwitter

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

FDA efforts to reduce animal testing favor AI, chips in research In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation remains regarding the impact this decision will ultimately have on research and development, prescribers and patients, and animal welfare. “The FDA’s April 10, 2025, announcement was a clear signal that the agency wants human-relevant evidence, or new approach methods, to increasingly replace or reduce certain traditional animal studies, starting with monoclonal antibodies, through a stepwise approach

Ophthopedia Update: FDA efforts to reduce animal testing favor AI, chips in research: In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches.
One year later,… #ophthalmology #eye #eyenews

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

1 day ago

REPLY We thank Benson et al for their thoughtful commentary on our article. We appreciate their engagement with this topic and their observation of similar increases in ophthalmic transfer volume at their academic institution, which aligns with the trends identified in our study.

Ophthopedia Update: REPLY: We thank Benson et al for their thoughtful commentary on our article. We appreciate their engagement with this topic and their observation of similar increases in ophthalmic transfer volume at their academic institution, which… #Ophthalmology #ophthotwitter #eyecare

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

2 days ago

Nebular Cortical Cataract in Stickler Syndrome A 12-year-old boy with a family history of Stickler syndrome presented with blurry vision. Examination revealed an empty-appearing vitreous and bilateral curvilinear lenticular opacities, consistent with cortical cataracts (right eye; A, right gaze; B, retro-illumination). Genetic testing confirmed a pathologic COL2A1 variant. Stickler syndrome is an autosomal dominant collagen disorder with well-known ophthalmic manifestations including severe myopia and lattice degeneration. There is a high lifetime risk of retinal detachment, which this patient developed years later.

Ophthopedia Update: Nebular Cortical Cataract in Stickler Syndrome: A 12-year-old boy with a family history of Stickler syndrome presented with blurry vision. Examination revealed an empty-appearing vitreous and bilateral curvilinear lenticular opacities,… #Ophthalmology #ophthotwitter #eyecare

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

2 days ago

Foveal Hypoplasia in Waardenburg Syndrome A 39-year-old woman was referred for suspicion of ocular albinism. Her medical history included congenital sensorineural hearing loss. Visual acuity was 20/32 in both eyes. Ophthalmoscopy revealed diffuse choroidal hypopigmentation (A). OCT and OCT-angiography demonstrated bilateral foveal hypoplasia with absence of the foveal avascular zone (B). Anterior segment examination showed complete hypoplastic blue irides (C). Examination of her 10-year-old daughter revealed segmental iris heterochromia in her left eye (D) and bilateral foveal hypoplasia.

Ophthopedia Update: Foveal Hypoplasia in Waardenburg Syndrome: A 39-year-old woman was referred for suspicion of ocular albinism. Her medical history included congenital sensorineural hearing loss. Visual acuity was 20/32 in both eyes. Ophthalmoscopy revealed… #Ophthalmology #ophthotwitter #eyecare

0 1 0 0

Ophthopedia

@ophthalmology.bsky.social

2 days ago

Effectiveness of Corticosteroid-Sparing Topical Treatments for Vernal Keratoconjunctivitis in Children - IN PRESS A variety of topical corticosteroid-sparing treatments can be used to improve the clinical signs and/or subjective patient symptoms of vernal keratoconjunctivitis in children 18 years old and younger.

Ophthopedia Update: Effectiveness of Corticosteroid-Sparing Topical Treatments for Vernal Keratoconjunctivitis in Children - IN PRESS: A variety of topical corticosteroid-sparing treatments can be used to improve the clinical signs and/or subjective patient symptoms of… #Ophthalmology #Eyecare

0 0 0 0

Wilayah My

@wilayahmy.bsky.social

2 days ago

Court of Appeal Upholds RM1.28m Compensation in Medical Negligence Case PUTRAJAYA — The Court of Appeal today rejected an appeal by an ophthalmologist seeking to overturn a High Court ruling that found him liable for medical negligence which resulted in a mechanic losing sight in one eye. A three-member panel comprising Datuk Dr Choo Kah Sing, Datuk Dr Shahnaz Sulaiman and Datuk Sri Latifah Mohd …

Court of Appeal Upholds RM1.28m Compensation in Medical Negligence Case #MedicalNegligence #CourtOfAppeal #Compensation #LegalNews #Ophthalmology

0 0 0 0

@longevitytech.bsky.social

2 days ago

Trials begin testing a longer-lasting therapy for diabetic eye disease, as researchers push to reduce treatment burden and protect vision

vist.ly/4uq5n

#longevity #ClinicalTrials #DiabeticRetinopathy #Ophthalmology #DrugDevelopment #Biotech

1 0 0 0

Ophthopedia

@ophthalmology.bsky.social

2 days ago

A third of Americans sacrifice basic needs to pay for health care Roughly one-third of U.S. adults — or more than 82 million people — cut back on basic needs such as food, utilities or transportation to pay for health care in the past year, according to new Gallup surveys. One survey of nearly 20,000 U.S. adults conducted from June through August 2025 found that 62% of uninsured Americans made at least one sacrifice to pay for health care, including 32% who borrowed funds and 24% who prolonged their medication, Gallup reported. Slightly more than half of households earning less than $24,000 per year responded this way, but Gallup noted that health care

Ophthopedia Update: A third of Americans sacrifice basic needs to pay for health care: Roughly one-third of U.S. adults — or more than 82 million people — cut back on basic needs such as food, utilities or transportation to pay for health care in the past year,… #ophthalmology #eye #eyenews

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

2 days ago

10-year experience in the use of Intravenous Immunoglobulin for Autoimmune Retinopathy Eye, Published online: 12 March 2026; doi:10.1038/s41433-026-04368-610-year experience in the use of Intravenous Immunoglobulin for Autoimmune Retinopathy

Ophthopedia Update: 10-year experience in the use of Intravenous Immunoglobulin for Autoimmune Retinopathy: Eye, Published online: 12 March 2026; doi:10.1038/s41433-026-04368-610-year experience in the use of Intravenous Immunoglobulin for Autoimmune Retinopathy #Ophthalmology #Eye #Ophthotwitter

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

2 days ago

The role of feedback in amblyopia treatment – a multi-centre randomised control trial Eye, Published online: 12 March 2026; doi:10.1038/s41433-026-04383-7The role of feedback in amblyopia treatment – a multi-centre randomised control trial

Ophthopedia Update: The role of feedback in amblyopia treatment – a multi-centre randomised control trial: Eye, Published online: 12 March 2026; doi:10.1038/s41433-026-04383-7The role of feedback in amblyopia treatment – a multi-centre randomised control trial #Ophthalmology #Eye #Ophthotwitter

0 0 0 0

Ophthopedia

@ophthalmology.bsky.social

2 days ago

High-Risk HPV May Be an Etiologic Factor in Lacrimal Sac SCC Development High-risk human papillomavirus (HR-HPV) is a known factor in certain head and neck cancers, and this small retrospective analysis found associations between HR-HPV and lacrimal sac squamous cell carcinoma (SCC).

Ophthopedia Update: High-Risk HPV May Be an Etiologic Factor in Lacrimal Sac SCC Development: High-risk human papillomavirus (HR-HPV) is a known factor in certain head and neck cancers, and this small retrospective analysis found associations between HR-HPV and lacrimal sac… #Ophthalmology #News

1 0 0 0

Ophthopedia

@ophthalmology.bsky.social

2 days ago

FDA approves Johnson & Johnson’s Tecnis PureSee IOL Editor’s note: This is a developing news story. Please check back soon for updates. The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release from Johnson & Johnson. A previous analysis of the lens found that 97% of patients reported “no very bothersome visual disturbances,” with 97% of patients reporting that they would recommend the IOL to friends and family. According to the release, this is the first FDAapproved extended depth of focus IOL with no warning on loss of contrast sensitivity. In addition, it reduces the impact

Ophthopedia Update: FDA approves Johnson & Johnson’s Tecnis PureSee IOL: Editor’s note: This is a developing news story. Please check back soon for updates.
The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a… #ophthalmology #eye #eyenews

0 0 0 0

Posts tagged #ophthalmology